Articles Posted in Ozempic

Ozempic, Wegovy, Rybelsus, and other GLP-1 medications are now the focus of a separate wave of lawsuits involving NAION, a rare optic nerve injury that can cause sudden and permanent vision loss. These cases allege that Novo Nordisk and other drugmakers failed to adequately warn patients and doctors that GLP-1 drugs may increase the risk of non-arteritic anterior ischemic optic neuropathy.

NAION is often described as an eye stroke. It usually causes sudden, painless vision loss in one eye, often noticed upon waking. The injury can be permanent. For many plaintiffs, that is what makes these claims so serious. The allegation is not temporary blurred vision or ordinary eye irritation, but rather the permanent loss of sight after using a drug that did not carry a clear warning about this risk.